Azacitidine prolongs survival in myelodysplastic syndromes

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1621, 2008-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Azacitidine: In Myelodysplastic Syndromes

By Siddiqui M. Asif A. Scott Lesley J.

Drugs, Vol. 65, Iss. 13, 2005-01 ,pp. : 1781-1789

Adis International

Access to resources Recommend Favorite

The role of azacitidine in the treatment of myelodysplastic syndromes

By Abdulhaq Haifaa Rossetti James M

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 12, 2007-12 ,pp. : 1967-1975

Informa Healthcare

Access to resources Recommend Favorite

Azacitidine in Myelodysplastic Syndromes: A Viewpoint by Valeria Santini

By Santini Valeria

Drugs, Vol. 65, Iss. 13, 2005-01 ,pp. : 1790-1791

Adis International

Access to resources Recommend Favorite

Azacitidine: A Review of its Use in the Management of Myelodysplastic Syndromes/Acute Myeloid Leukaemia

By Keating Gillian M.

Drugs, Vol. 72, Iss. 8, 2012-05 ,pp. : 1111-1136

Adis International

Access to resources Recommend Favorite

Azacitidine beneficial in myelodysplastic syndrome

Inpharma, Vol. 1, Iss. 1348, 2002-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite